Gerald A. Maguire, MD joins Peter Reitzes to discuss what speech-language pathologists need to know about the emerging medical treatments in stuttering.
StutterTalk is excited to announce that this StutterTalk episode or course will be available for 0.10 CEUs for approximately six months, free of charge, through the National Stuttering Association. For complete details regarding the continuing education units being offered by the National Stuttering Association, go to the National Stuttering Association’s CEU page.
Take the CEU Test Here.(expired May 15, 2014)
Show/Course Notes:
Title: What Speech-Language Pathologists Need to Know About the Emerging Medical Treatments in Stuttering
Objectives: At the conclusion of the program, the learner shall be able to:
Identify the new DSM 5 criteria for childhood onset fluency disorder (stuttering)
Summarize available pharmacologic treatments for stuttering and related conditions.
Cite how traditional speech therapy with people who stutter is commonly effected by the medical treatment of stuttering.
Presenter Bio — Gerald A. Maguire, MD, is Sr. Associate Dean of Medical Education, holds the Kirkup Endowed Chair in Stuttering Treatment and is Professor of Clinical Psychiatry at the University of California Irvine School of Medicine. Dr. Maguire is a regular guest on StutterTalk. His previous appearances are archived here. Contact Dr. Maguire directly via email: gerald.maguire@uci.edu.
Episode/Course Description: Stuttering has recently been reclassified in DSM 5 as Childhood Onset Fluency Disorder. Over the past decade, much has been learned regarding the neurophysiologic and genetic basis of stuttering. With such, methods for medical treatments have emerged. Such treatments can potentially be utilized when standard speech therapy techniques have not yielded full benefits or as an augmentation to such treatments.
CARYN HERRING, ROISIN MCMANUS and JOEL KORTE of The Stuttertalk B Team discuss the different flavors of voluntary stuttering and how this fits into stuttering management. They finish up the show by talking about the the potential discomfort associated with struggle and loss of control.
ROBERT QUESAL, Ph.D., CCC-SLP is a professor of Communication Sciences and Disorders at Western Illinois University, a person who stutters, a board recognized fluency specialist and a fellow of the American Speech-Language-Hearing Association. Dr. Quesal’s appearances on StutterTalk are archived here.
Robert “the Expert” Quesal joins Peter Reitzes to discuss stuttering in the media. They discuss the use of stuttering on the situational comedy It’s Always Sunny in Philadelphia (Season 9, Episode 7). Then they discuss a story out of the United Kingdom (see video below) regarding a 16-year-old high school student, Musharaf “Mushy” Asghar , who is fearful of taking his oral exams. One of Mr. Asghar’s teachers, influenced by the film The King’s Speech, has Mushy practice speaking while wearing headphones and listening to music.
ROBERT QUESAL, Ph.D., CCC-SLP is a professor of Communication Sciences and Disorders at Western Illinois University, a person who stutters, a board recognized fluency specialist and a fellow of the American Speech-Language-Hearing Association.
This week we feature a Classic Episode from December 31, 2009 titled What Interferes with Forward Moving Speech. Join us next week for a new episode of StutterTalk.
This is the third and final show that StutterTalk recorded in Albany, New York in 2009. Dr. Joe Klein joins Peter Reitzes and Eric Jackson to discuss Dean Williams’ therapy and thoughts on stuttering, harnessing “normal” or non-stuttered speech, identifying what interferes with forward moving speech and much, much more.
CARYN HERRING, ROISIN MCMANUS and JOEL KORTE ( of the “Stuttertalk B Team”) reminisce about Joel’s recent wedding and discuss how stuttering played a part in the day. Later, Roisin talks about advertising to new people at work. They wrap up the show by discussing Caryn’s recent experience providing speech therapy at Camp OurTime.
StutterTalk® is a 501 (c)(3) non-profit organization dedicated to talking openly about stuttering. StutterTalk is the first and longest running podcast on stuttering. Since 2007 we have published more than 700 podcasts which are heard in 180 countries.
15 Nov 2013
What Speech-Language Pathologists Need to Know About the Emerging Medical Treatments in Stuttering (Ep. 429)
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Google Podcasts | Stitcher | TuneIn | RSS
Gerald A. Maguire, MD joins Peter Reitzes to discuss what speech-language pathologists need to know about the emerging medical treatments in stuttering.
StutterTalk is excited to announce that this StutterTalk episode or course will be available for 0.10 CEUs for approximately six months, free of charge, through the National Stuttering Association. For complete details regarding the continuing education units being offered by the National Stuttering Association, go to the National Stuttering Association’s CEU page.
Take the CEU Test Here.(expired May 15, 2014)Show/Course Notes:
Title: What Speech-Language Pathologists Need to Know About the Emerging Medical Treatments in Stuttering
Objectives: At the conclusion of the program, the learner shall be able to:
Presenter Bio — Gerald A. Maguire, MD, is Sr. Associate Dean of Medical Education, holds the Kirkup Endowed Chair in Stuttering Treatment and is Professor of Clinical Psychiatry at the University of California Irvine School of Medicine. Dr. Maguire is a regular guest on StutterTalk. His previous appearances are archived here. Contact Dr. Maguire directly via email: gerald.maguire@uci.edu.
Episode/Course Description: Stuttering has recently been reclassified in DSM 5 as Childhood Onset Fluency Disorder. Over the past decade, much has been learned regarding the neurophysiologic and genetic basis of stuttering. With such, methods for medical treatments have emerged. Such treatments can potentially be utilized when standard speech therapy techniques have not yielded full benefits or as an augmentation to such treatments.
Presenter’s Financial Disclosures: Research Grants: Otsuka, Merck. Speaking/Consulting: Lilly, Novartis, Merck, Sunovion, Assurex, Lundbeck, Otsuka, Takeda